News
In the first quarter, Dexcom’s G7 system continued its robust momentum. Accelerated conversion of the installed base for G7 manufacturing is driving strong revenue performance and improving ...
DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) ...
It offers various medical devices and products, including Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. On May 5, Analyst Mike Kratky from Leerink ...
After a type 1.5 diabetes diagnosis in 2021, Lance Bass found a new path to health, balance, and saying yes to life.
Dexcom CEO Kevin Sayer touted the company’s recent efforts to expand coverage of CGMs for people with Type 2 diabetes. On a May 1 earnings call, the CEO told investors that all three major U.S.
Detailed price information for American Diversified Holdings Corp (ADHC) from The Globe and Mail including charting and ...
Best Buy initiated a major restructuring effort within its health business in the first quarter of fiscal year 2026, incurring $109 million in restructuring charges.
Hosted on MSN21d
Here's Why You Should Add DexCom Stock to Your Portfolio NowNew Product Launch: Dexcom plans to launch a 15-day G7 sensor in the second half of 2025, which is expected to bolster margins and enhance user experience.Additionally, efforts are underway to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results